The Identification of Immunological Biomarkers in Kidney Cancers

The recent approval of several agents have revolutionized the scenario of therapeutic management of metastatic renal cell carcinoma (RCC) allowing us to reach important clinical end points with extended patients' survival. Actually, every new drug approved has represented an important step forw...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Beltran, Antonio, Henriques, Vanessa, Cimadamore, Alessia, Santoni, Matteo, Cheng, Liang, Gevaert, Thomas, Blanca, Ana, Massari, Francesco, Scarpelli, Marina, Montironi, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225533/
https://www.ncbi.nlm.nih.gov/pubmed/30450335
http://dx.doi.org/10.3389/fonc.2018.00456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225533/
https://www.ncbi.nlm.nih.gov/pubmed/30450335
http://dx.doi.org/10.3389/fonc.2018.00456

Ejemplares similares